LT3468957T - (r)-4-(5-(ciklopropiletil)izoksazol-3-il)-n-hidroksi-2-metil-2-(metilsulfonil)butanamido kristalinė forma kaip antibakterinis agentas - Google Patents

(r)-4-(5-(ciklopropiletil)izoksazol-3-il)-n-hidroksi-2-metil-2-(metilsulfonil)butanamido kristalinė forma kaip antibakterinis agentas

Info

Publication number
LT3468957T
LT3468957T LTEP17739696.7T LT17739696T LT3468957T LT 3468957 T LT3468957 T LT 3468957T LT 17739696 T LT17739696 T LT 17739696T LT 3468957 T LT3468957 T LT 3468957T
Authority
LT
Lithuania
Prior art keywords
cyclopropylethynyl
butanamide
isoxazol
methylsulfonyl
hydroxy
Prior art date
Application number
LTEP17739696.7T
Other languages
English (en)
Inventor
Jiping Fu
Siyi Jiang
Andreas Kordikowski
Zachary Kevin Sweeney
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Priority claimed from PCT/IB2017/053468 external-priority patent/WO2017216705A1/en
Publication of LT3468957T publication Critical patent/LT3468957T/lt

Links

LTEP17739696.7T 2016-06-14 2017-06-12 (r)-4-(5-(ciklopropiletil)izoksazol-3-il)-n-hidroksi-2-metil-2-(metilsulfonil)butanamido kristalinė forma kaip antibakterinis agentas LT3468957T (lt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN2016000856 2016-06-14
PCT/IB2017/053468 WO2017216705A1 (en) 2016-06-14 2017-06-12 Crystalline form of (r)-4-(5-(cyclopropylethynyl)isoxazol-3-yl)-n-hydroxy-2-methyl-2-(methylsulfonyl)butanamide as an antibacterial agent

Publications (1)

Publication Number Publication Date
LT3468957T true LT3468957T (lt) 2020-10-12

Family

ID=72713492

Family Applications (1)

Application Number Title Priority Date Filing Date
LTEP17739696.7T LT3468957T (lt) 2016-06-14 2017-06-12 (r)-4-(5-(ciklopropiletil)izoksazol-3-il)-n-hidroksi-2-metil-2-(metilsulfonil)butanamido kristalinė forma kaip antibakterinis agentas

Country Status (1)

Country Link
LT (1) LT3468957T (lt)

Similar Documents

Publication Publication Date Title
IL266214A (en) 5,4,2-trisubstituted 4,2,1-triazolones used as DHODH inhibitors
IL262549B (en) Using types of compounds as a substance that contains energy
IL274488B1 (en) Crystal forms of n-(4-(4-(cyclopropylmethyl)piperazine-1-carbonyl)phenyl)quinoline-8-sulfonamide
EP3364968A4 (en) OXAZOLIDINONE COMPOUNDS AND USES THEREOF AS ANTIBACTERIAL AGENTS
IL272888B1 (en) Uses of piperidinyl-indole derivatives
IL251037A0 (en) Crystal structures of 6-carboxy-2-(5,3-dichlorophenyl)-benzoxazole
IL271962A (en) Preparation of 3-aryl-5-trifluoromethyl-4,2,1-converted oxadiazoles
ZA201903075B (en) Thermoassociative additive compositions, the association of which is controlled, and lubricating compositions containing same
IL273896A (en) Crystal forms of 3-disubstituted 1, 2, 4-oxadiazole
EP3237413A4 (en) Compositions of fatostatin based heterocyclic compounds and uses thereof
EP3398942A4 (en) Substituted oxadiazole chemical compound and composition containing said chemical compound and use thereof
HK1254491A1 (zh) 用於手術應用的抗微生物組合物
PL3532457T3 (pl) Postacie krystaliczne hydroksynorketaminy
IL263299A (en) Crystalline form of (r)-4-(5-(cyclopropylethynyl)isoxazol-3-yl)-n-hydroxy-2-methyl-2-(methylsulfonyl)butanamide as an antibacterial agent
IL270961A (en) Crystalline form of N-butyldeoxygalactonogirimycin
ZA202000464B (en) Benzoxazinone derivatives useful as herbicides
IL269792B (en) Crystalline forms of (s)–apoxolner
EP3160230C0 (en) FORMULATION OF CLOMAZONE WITH REDUCED VOLATILITY
LT3468957T (lt) (r)-4-(5-(ciklopropiletil)izoksazol-3-il)-n-hidroksi-2-metil-2-(metilsulfonil)butanamido kristalinė forma kaip antibakterinis agentas
EP3303470A4 (en) Perfluoroelastomeric compositions comprising oxazoles
SI3143019T1 (sl) Kristalna oblika 6-((4R)-4-metil-1,2-dioksido-1,2,6-tiadiazinan-2-IL)isokvinolin-1- karbonitrila
ZA201801120B (en) Oxazolidinone compounds and methods of use thereof as antibacterial agents
GB201716293D0 (en) Novel formulations of aprepitant
IL270937A (en) Crystalline forms of saltalicib
GB201621867D0 (en) Novel formulations of aprepitant